Anti-LGI1 encephalitis following COVID-19 vaccination: a case series
J Neurol
.
2022 Nov;269(11):5720-5723.
doi: 10.1007/s00415-022-11234-4.
Epub 2022 Jun 25.
Authors
Gian Maria Asioli
#
1
2
,
Lorenzo Muccioli
#
3
,
Valentina Barone
3
,
Sebastiano Giacomozzi
3
,
Simone Rossi
4
3
,
Tania Silvestri
5
,
Luca Spinardi
4
,
Vincenzo Mastrangelo
6
,
Giorgia Bernabè
6
,
Chiara Leta
6
,
Mariachiara Brutto
3
,
Chiara Faggiano
7
,
Rocco Liguori
4
3
,
Francesca Bisulli
4
3
,
Marco Longoni
6
8
,
Paolo Tinuper
4
3
,
Maria Guarino
4
,
Pietro Cortelli
4
3
Affiliations
1
IRCCS Istituto Delle Scienze Neurologiche di Bologna, Policlinico Sant'Orsola-Malpighi, via Palagi 20, Bologna, Italy. gianmaria.asioli@gmail.com.
2
Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy. gianmaria.asioli@gmail.com.
3
Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
4
IRCCS Istituto Delle Scienze Neurologiche di Bologna, Policlinico Sant'Orsola-Malpighi, via Palagi 20, Bologna, Italy.
5
Metropolitan Laboratory, AUSL Bologna, Bologna, Italy.
6
Neurology Unit, Rimini "Infermi" Hospital, AUSL Romagna, Rimini, Italy.
7
Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
8
Neurology and Stroke Unit, Department of Neuroscience, "Maurizio Bufalini" Hospital, Cesena, Italy.
#
Contributed equally.
PMID:
35751687
PMCID:
PMC9243946
DOI:
10.1007/s00415-022-11234-4
No abstract available
Publication types
Letter
MeSH terms
Autoantibodies
COVID-19 Vaccines / adverse effects
COVID-19*
Encephalitis* / etiology
Humans
Limbic Encephalitis*
Vaccination / adverse effects
Substances
Autoantibodies
COVID-19 Vaccines